the Health Sector Reform Strategy. The last section concludes and provides some policy recommendations. …

information needed by policymakers, investors, and other interested stakeholders. To better understand the current health care …

Regulation fostering Managed Care alternatives in health insurance is spreading. This work reports on an experiment …-Care type restrictions in the provision of health care. It finds that restrictions on the freedom of physician choice would … willingness to pay. Marked preference heterogeneity is an argument against regulation imposing uniformity of contract in Swiss …

We assess quantitatively the effect of exogenous health improvements on output per capita. Our simulation model allows … for a direct effect of health on worker productivity, as well as indirect effects that run through schooling, the size and … developing countries, and standard components of quantitative macroeconomic theory. We consider both changes in general health …

This paper investigates the sensitivity of the intergenerational transmission of health to exogenous changes in income …, education and public health, changes that are often delivered by economic growth. It uses individual survey data on 2.24 million … maternal and child health as well as in aggregate economic conditions. The country-level panel is exploited to control for …

This paper is motivated to investigate the often neglected payoff to investments in the health of girls and women in … terms of next generation outcomes. This paper investigates the intergenerational persistence of health across time and … region as well as across the distribution of maternal health. It uses comparable micro-data on as many as 2.24 million …

Taking into account recent health care reforms in Germany a change of the structure in the provision of HIV health care … health-political and health-economic challenges for HIV health care. As a result challenges for five stakeholder groups could … be identified: health care providers, third party payers, the pharmaceutical industry, health politicians, and patients …